Dr. Kim Ekroos obtained his PhD in biology from the Technical University in Dresden, Germany, in 2003. In 2004 he started his postdoctoral work at the department of DMPK & Bioanalytical Chemistry at AstraZeneca in Mölndal, Sweden. In 2008 he joined Zora Biosciences Oy and became chief technology officer in 2013. Today, he runs his own consulting business, providing unique consulting services for customers globally in the field of lipidomics, the comprehensive analysis of a cell or organism’s lipid profile. He provides expert help and training in any phase of lipidomics. He focuses on developing and utilizing novel mass spectrometry high-throughput technologies for the precise assessment of lipidomes enabled by advanced mass spectrometry, automation and software tools. He is a member of the European Lipidomics Meeting committee and co-founder of the International Lipidomics Society.